Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy
Authors
Keywords
-
Journal
DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-01
DOI
10.1007/s40265-019-01171-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Hippocampus: Cannabidiol Blunts Δ9-Tetrahydrocannabinol-Induced Cognitive Impairment
- (2019) Ester Aso et al. MOLECULAR NEUROBIOLOGY
- Cannabinoid Ligands Targeting TRP Channels
- (2019) Chanté Muller et al. Frontiers in Molecular Neuroscience
- Galenic Preparations of Therapeutic Cannabis sativa Differ in Cannabinoids Concentration: A Quantitative Analysis of Variability and Possible Clinical Implications
- (2019) Alessandra Bettiol et al. Frontiers in Pharmacology
- Corrigendum: Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis
- (2019) Fabricio A. Pamplona et al. Frontiers in Neurology
- Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders
- (2019) Daniel Friedman et al. LANCET NEUROLOGY
- A Phase 1, Open‐Label, Parallel‐Group, Single‐Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment
- (2019) Lesley Taylor et al. JOURNAL OF CLINICAL PHARMACOLOGY
- A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential
- (2019) C. Michael White JOURNAL OF CLINICAL PHARMACOLOGY
- Cannabis for refractory epilepsy in children: A review focusing on CDKL5 Deficiency Disorder
- (2019) Tristan Dale et al. EPILEPSY RESEARCH
- Cannabidiol in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study
- (2019) Elizabeth Thiele et al. EPILEPSIA
- Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy
- (2019) James W. Wheless et al. CNS DRUGS
- Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy
- (2019) Angela K. Birnbaum et al. EPILEPSIA
- Effects of cannabidiol on brivaracetam plasma levels
- (2019) Kerstin A. Klotz et al. EPILEPSIA
- Phyto and endocannabinoids exert complex actions on calcium and zinc signaling in mouse cortical neurons
- (2018) Alexandre Bouron BIOCHEMICAL PHARMACOLOGY
- Cannabis Contaminants - sources, distribution, human toxicity and pharmacologic effects
- (2018) Laura M. Dryburgh et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors
- (2018) Mylyne Tham et al. BRITISH JOURNAL OF PHARMACOLOGY
- Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results
- (2018) Jerzy P. Szaflarski et al. EPILEPSIA
- Open-label use of Highly* purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes
- (2018) Orrin Devinsky et al. EPILEPSY & BEHAVIOR
- Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence
- (2018) Emily Stockings et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Quality Traits of “Cannabidiol Oils”: Cannabinoids Content, Terpene Fingerprint and Oxidation Stability of European Commercially Available Preparations
- (2018) Radmila Pavlovic et al. MOLECULES
- Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
- (2018) Orrin Devinsky et al. NEUROLOGY
- Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
- (2018) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?
- (2018) Fernanda F. Peres et al. Frontiers in Pharmacology
- Cannabinoid-Based Therapies and Brain Development: Potential Harmful Effect of Early Modulation of the Endocannabinoid System
- (2018) Patrícia Schonhofen et al. CNS DRUGS
- Cannabis for the Treatment of Epilepsy: an Update
- (2018) Tyler E. Gaston et al. Current Neurology and Neuroscience Reports
- Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study
- (2018) Jerzy P. Szaflarski et al. EPILEPSY & BEHAVIOR
- Inhibitory effects of cannabidiol on voltage-dependent sodium currents
- (2018) Mohammad-Reza Ghovanloo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome
- (2018) Bláthnaid McCoy et al. Annals of Clinical and Translational Neurology
- Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US
- (2018) Tristan T. Sands et al. CNS DRUGS
- A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
- (2018) Lesley Taylor et al. CNS DRUGS
- Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis
- (2018) Simona Lattanzi et al. DRUGS
- Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). II. Drugs in more advanced clinical development
- (2018) Meir Bialer et al. EPILEPSIA
- Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models
- (2018) Pabitra Hriday Patra et al. EPILEPSIA
- Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial
- (2018) Orrin Devinsky et al. EPILEPSIA
- Cannabis-based products for pediatric epilepsy: A systematic review
- (2018) Jesse Elliott et al. EPILEPSIA
- Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial
- (2018) Kerri A. Schoedel et al. EPILEPSY & BEHAVIOR
- A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
- (2018) Sophie A. Millar et al. Frontiers in Pharmacology
- Interactions between cannabidiol and commonly used antiepileptic drugs
- (2017) Tyler E. Gaston et al. EPILEPSIA
- Quality of Life in Childhood Epilepsy in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol
- (2017) Evan C. Rosenberg et al. EPILEPSIA
- Cannabis and epilepsy: An ancient treatment returns to the fore
- (2017) Ethan B. Russo EPILEPSY & BEHAVIOR
- Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection
- (2017) Evan C. Rosenberg et al. EPILEPSY & BEHAVIOR
- Anticonvulsant effect of cannabidiol in the pentylenetetrazole model: Pharmacological mechanisms, electroencephalographic profile, and brain cytokine levels
- (2017) Luciano R. Vilela et al. EPILEPSY & BEHAVIOR
- Pharmacology of cannabinoids in the treatment of epilepsy
- (2017) Tyler E. Gaston et al. EPILEPSY & BEHAVIOR
- Historical perspective on the medical use of cannabis for epilepsy: Ancient times to the 1980s
- (2017) Daniel Friedman et al. EPILEPSY & BEHAVIOR
- Interactions between cannabidiol and Δ9-THC following acute and repeated dosing: Rebound hyperactivity, sensorimotor gating and epigenetic and neuroadaptive changes in the mesolimbic pathway
- (2017) Stephanie M. Todd et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Labeling Accuracy of Cannabidiol Extracts Sold Online
- (2017) Marcel O. Bonn-Miller et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cannabinoids concentration variability in cannabis olive oil galenic preparations
- (2017) Chiara Carcieri et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP)
- (2017) Brian D. Klein et al. NEUROCHEMICAL RESEARCH
- Cannabinoids as hippocampal network administrators
- (2017) Carl R. Lupica et al. NEUROPHARMACOLOGY
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cannabidiol in medical marijuana: Research vistas and potential opportunities
- (2017) Carola Rong et al. PHARMACOLOGICAL RESEARCH
- Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome
- (2017) Joshua S. Kaplan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe Epilepsy
- (2017) Raquel A. Do Val-da Silva et al. Frontiers in Pharmacology
- Cannabinoids and Cytochrome P450 Interactions
- (2016) Ondřej Zendulka et al. CURRENT DRUG METABOLISM
- Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex
- (2016) Evan J. Hess et al. EPILEPSIA
- Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases
- (2016) Jacqueline S. Gofshteyn et al. JOURNAL OF CHILD NEUROLOGY
- Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
- (2016) Orrin Devinsky et al. LANCET NEUROLOGY
- Cannabidiol and epilepsy: Rationale and therapeutic potential
- (2016) Antonio Leo et al. PHARMACOLOGICAL RESEARCH
- Cannabidiol Mellows Out Resurgent Sodium Current
- (2016) Christopher H. Thompson et al. Epilepsy Currents
- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Neural correlates of interactions between cannabidiol and Δ9-tetrahydrocannabinol in mice: implications for medical cannabis
- (2015) S M Todd et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
- (2015) Alexandra L. Geffrey et al. EPILEPSIA
- Cannabinoids: is there a potential treatment role in epilepsy?
- (2015) Robert E Blair et al. EXPERT OPINION ON PHARMACOTHERAPY
- Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products
- (2015) Ryan Vandrey et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy
- (2015) Ivan Soltesz et al. NATURE REVIEWS NEUROSCIENCE
- Molecular Targets of Cannabidiol in Neurological Disorders
- (2015) Clementino Ibeas Bih et al. Neurotherapeutics
- Cannabidiol, a Cannabis sativa constituent, inhibits cocaine-induced seizures in mice: Possible role of the mTOR pathway and reduction in glutamate release
- (2015) Pedro H. Gobira et al. NEUROTOXICOLOGY
- Cannabinoids in the Treatment of Epilepsy
- (2015) Daniel Friedman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pure Cannabidiol in the Treatment of Malignant Migrating Partial Seizures in Infancy: A Case Report
- (2015) Dimah Saade et al. PEDIATRIC NEUROLOGY
- Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability
- (2014) Fabio Arturo Iannotti et al. ACS Chemical Neuroscience
- The case for medical marijuana in epilepsy
- (2014) Edward Maa et al. EPILEPSIA
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- (2014) Orrin Devinsky et al. EPILEPSIA
- Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology
- (2014) B. S. Koppel et al. NEUROLOGY
- Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se
- (2014) Andrew J. Hill et al. NEUROSCIENCE LETTERS
- Cannabidiol Is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19
- (2013) Rongrong Jiang et al. Drug Metabolism and Pharmacokinetics
- Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review
- (2013) Stephen M. Stout et al. DRUG METABOLISM REVIEWS
- A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers
- (2013) Colin Stott et al. SpringerPlus
- Does Cannabidiol Protect Against Adverse Psychological Effects of THC?
- (2013) Raymond J. M. Niesink et al. Frontiers in Psychiatry
- Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
- (2012) Amir Englund et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures
- (2012) Nicholas A. Jones et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis
- (2011) K. Goffin et al. BRAIN
- Cannabidiol, a Major Phytocannabinoid, As a Potent Atypical Inhibitor for CYP2D6
- (2011) S. Yamaori et al. DRUG METABOLISM AND DISPOSITION
- Cannabinoids inhibit the synaptic uptake of adenosine and dopamine in the rat and mouse striatum
- (2011) Pablo Pandolfo et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Marijuana, endocannabinoids, and epilepsy: Potential and challenges for improved therapeutic intervention
- (2011) Mackenzie E. Hofmann et al. EXPERIMENTAL NEUROLOGY
- Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes
- (2011) Rongrong Jiang et al. LIFE SCIENCES
- Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: Role of phenolic hydroxyl groups in the resorcinol moiety
- (2011) Satoshi Yamaori et al. LIFE SCIENCES
- Cannabidiol inhibits synaptic transmission in rat hippocampal cultures and slices via multiple receptor pathways
- (2010) CJ Ledgerwood et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of cannabinoids and cannabinoid-enrichedCannabisextracts on TRP channels and endocannabinoid metabolic enzymes
- (2010) Luciano De Petrocellis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Dynamic changes of CB1-receptor expression in hippocampi of epileptic mice and humans
- (2010) Zsófia Maglóczky et al. EPILEPSIA
- Characterization of Human Hepatic and Extrahepatic UDP-Glucuronosyltransferase Enzymes Involved in the Metabolism of Classic Cannabinoids
- (2009) A. Mazur et al. DRUG METABOLISM AND DISPOSITION
- Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy
- (2009) Andrea Romigi et al. EPILEPSIA
- Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo
- (2009) N. A. Jones et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Downregulation of the CB1 Cannabinoid Receptor and Related Molecular Elements of the Endocannabinoid System in Epileptic Human Hippocampus
- (2008) A. Ludanyi et al. JOURNAL OF NEUROSCIENCE
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search